These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 16344387)

  • 1. Arrhythmogenic right ventricular dysplasia: a United States experience.
    Dalal D; Nasir K; Bomma C; Prakasa K; Tandri H; Piccini J; Roguin A; Tichnell C; James C; Russell SD; Judge DP; Abraham T; Spevak PJ; Bluemke DA; Calkins H
    Circulation; 2005 Dec; 112(25):3823-32. PubMed ID: 16344387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Ma KJ; Li N; Wang HT; Chu JM; Fang PH; Yao Y; Ma J; Hua W; Zhang S; Wang FZ; Li Z; Pu JL
    Chin Med J (Engl); 2009 May; 122(10):1133-8. PubMed ID: 19493458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Hulot JS; Jouven X; Empana JP; Frank R; Fontaine G
    Circulation; 2004 Oct; 110(14):1879-84. PubMed ID: 15451782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial form of arrhythmogenic right ventricular cardiomyopathy.
    Włodarska EK; Konka M; Kepski R; Zaleska T; Płoski R; Ruzyłło W; Janion M; Jaworska K; Rydlewska-Sadowska W; Hoffman P
    Kardiol Pol; 2004 Jan; 60(1):1-14. PubMed ID: 15004627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
    James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
    Piccini JP; Dalal D; Roguin A; Bomma C; Cheng A; Prakasa K; Dong J; Tichnell C; James C; Russell S; Crosson J; Berger RD; Marine JE; Tomaselli G; Calkins H
    Heart Rhythm; 2005 Nov; 2(11):1188-94. PubMed ID: 16253908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
    Groeneweg JA; Bhonsale A; James CA; te Riele AS; Dooijes D; Tichnell C; Murray B; Wiesfeld AC; Sawant AC; Kassamali B; Atsma DE; Volders PG; de Groot NM; de Boer K; Zimmerman SL; Kamel IR; van der Heijden JF; Russell SD; Jan Cramer M; Tedford RJ; Doevendans PA; van Veen TA; Tandri H; Wilde AA; Judge DP; van Tintelen JP; Hauer RN; Calkins H
    Circ Cardiovasc Genet; 2015 Jun; 8(3):437-46. PubMed ID: 25820315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
    Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent syncope episodes in a 33-year-old male patient: case report and review of literature.
    Del Rio-Santiago V; Vicenty-Rivera SI; Judge D; Ortiz-Muñoz L
    Bol Asoc Med P R; 2008; 100(4):89-98. PubMed ID: 19400535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital.
    Peters S; Trümmel M; Meyners W
    Int J Cardiol; 2004 Dec; 97(3):499-501. PubMed ID: 15561339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.